Postmenopausal hormone replacement therapy and cardiovascucular disease, Women Vascular Health, pp.436-453, 2007. ,
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?, The Lancet, vol.352, issue.9128, pp.609-622, 1998. ,
DOI : 10.1016/S0140-6736(98)01085-X
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement, The Lancet, vol.354, issue.9193, pp.1896-900, 1999. ,
DOI : 10.1016/S0140-6736(99)04149-5
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>, JAMA, vol.283, issue.15, pp.2008-2020, 2000. ,
DOI : 10.1001/jama.283.15.2008
QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1, Epidemiologic Reviews, vol.9, issue.1, pp.1-30, 1987. ,
DOI : 10.1093/oxfordjournals.epirev.a036298
Measuring inconsistency in meta-analyses, BMJ, vol.327, issue.7414, pp.557-60, 2003. ,
DOI : 10.1136/bmj.327.7414.557
Meta-analysis in clinical trials, Controlled Clinical Trials, vol.7, issue.3, pp.177-88, 1986. ,
DOI : 10.1016/0197-2456(86)90046-2
Review papers : The statistical basis of meta-analysis, Statistical Methods in Medical Research, vol.2, issue.2, pp.121-166, 1993. ,
DOI : 10.1177/096228029300200202
Is the current classification of venous thromboembolism acceptable? No, Journal of Thrombosis and Haemostasis, vol.125, issue.12, pp.2262-2265, 2004. ,
DOI : 10.1016/S0140-6736(03)14111-6
Genetic aspects of venous thrombosis, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.95, issue.2, pp.189-92, 2001. ,
DOI : 10.1016/S0301-2115(00)00488-7
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 casecontrol studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism, Thromb Haemost, vol.86, issue.3, pp.809-825, 2001. ,
Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group, Thromb Haemost, vol.83, issue.5, pp.657-60, 2000. ,
URL : https://hal.archives-ouvertes.fr/hal-00726218
Estrogen Plus Progestin and Risk of Venous Thrombosis, JAMA, vol.292, issue.13, pp.1573-80, 2004. ,
DOI : 10.1001/jama.292.13.1573
Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein--a cross-sectional population survey, Thromb Haemost, vol.86, issue.2, pp.550-556, 2001. ,
Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal Women : A Randomized Controlled Trial, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.17, issue.11, pp.3071-3079, 1997. ,
DOI : 10.1161/01.ATV.17.11.3071
Differential Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Sensitivity to Activated Protein C Among Postmenopausal Women: A Randomized Trial, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.9, pp.1671-1677, 2003. ,
DOI : 10.1161/01.ATV.0000087141.05044.1F
URL : https://hal.archives-ouvertes.fr/hal-00722263
Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET), Thromb Haemost, vol.84, issue.6, pp.961-968, 2000. ,
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis, N Engl J Med, vol.343, issue.8, pp.522-531, 2000. ,
A clinical trial of estrogen-replacement therapy after ischemic stroke, N Engl J Med, vol.345, issue.17, pp.1243-1252, 2001. ,
Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial, Lancet, vol.360, issue.9350, pp.2001-2009, 2002. ,
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, Jama, vol.288, issue.3, pp.321-354, 2002. ,
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, Jama, vol.291, issue.14, pp.1701-1713, 2004. ,
Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women):239. w21 Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Bmj N Engl J Med, vol.335290, issue.76131, pp.15-24, 1974. ,
Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors, JAMA: The Journal of the American Medical Association, vol.242, issue.11, pp.1150-1154, 1979. ,
DOI : 10.1001/jama.242.11.1150
Estrogen replacement therapy and the risk of venous thrombosis, The American Journal of Medicine, vol.92, issue.3, pp.275-82, 1992. ,
DOI : 10.1016/0002-9343(92)90077-O
Effects of long-term estrogen replacement therapy, American Journal of Obstetrics and Gynecology, vol.133, issue.5, pp.525-3634, 1979. ,
DOI : 10.1016/0002-9378(79)90288-6
A prospective investigation of pulmonary embolism in women and men, Jama, vol.268, issue.13, pp.1689-96, 1992. ,
Estrogen plus progestin and risk of venous thrombosis, Jama, vol.292, issue.13, pp.1573-80, 2004. ,
Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus, Archives of Internal Medicine, vol.166, issue.7, pp.772-80, 2006. ,
DOI : 10.1001/archinte.166.7.772
Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis, Arterioscler Thromb Vasc Biol Br J Haematol, vol.22116, issue.64, pp.1012-7851, 2002. ,
Prothrombotic Mutations, Hormone Therapy, and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration, Circulation, vol.112, issue.22, pp.3495-500, 2005. ,
DOI : 10.1161/CIRCULATIONAHA.105.565556
Conjugated Equine Estrogen, Esterified Estrogen, Prothrombotic Variants, and the Risk of Venous Thrombosis in Postmenopausal Women, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.12, pp.2807-2819, 2006. ,
DOI : 10.1161/01.ATV.0000245792.62517.3b
Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study, J Thromb Haemost, vol.4, issue.6, pp.1259-65, 2006. ,
URL : https://hal.archives-ouvertes.fr/inserm-00085273